<DOC>
	<DOCNO>NCT01371838</DOCNO>
	<brief_summary>This purpose study Evaluate Efficacy Safety Intravenous Ceftaroline Versus Intravenous Ceftriaxone Treatment Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia Asia .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Intravenous Ceftaroline Versus Intravenous Ceftriaxone Treatment Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia Asia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>Males females 18 year age Lung Infection Individual Recently Hospitalized meeting follow criterion : Radiographicallyconfirmed pneumonia ( new progressive infection site lung ) consistent bacterial pneumonia ) , AND Acute illness ( ≤ 7 day duration ) least three follow clinical sign symptom consistent lung infection : New increase cough , Purulent sputum change sputum character , Auscultatory finding consistent pneumonia , Difficulty breathing , short breath , decrease partial pressure oxygen blood , Fever great 38ºC oral body temperature lower require normal body function ( &lt; 35ºC ) , White blood cell count great less normal , Greater 15 % immature neutrophil ( band ) irrespective white blood cell count , AND Moderate lung infection The subject must require initial hospitalization , treatment emergency room urgent care set , standard care The subject 's infection would require initial treatment intravenous antimicrobial Female subject childbearing potential , few 2 year postmenopausal , must agree , comply , use highly effective method birth control participate study Lung Infection Individual Recently Hospitalized suitable outpatient therapy oral antimicrobial agent Confirmed suspect respiratory tract infection attributable source bacteria individual recently hospitalize ( e.g. , ventilatorassociated pneumonia , hospitalacquired pneumonia , visible/gross aspiration pneumonia , suspected viral , fungal , mycobacterial infection lung ) Noninfectious cause lung lesion ( e.g. , pulmonary embolism , chemical pneumonitis aspiration , hypersensitivity pneumonia , congestive heart failure ) Accumulation pus pleural cavity Microbiologicallydocumented infection pathogen know resistant ceftriaxone , epidemiological clinical context suggest high likelihood ceftriaxoneresistant `` typical '' bacterial pathogen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Community-Acquired Bacterial Pneumonia</keyword>
</DOC>